The DOI matches its Crossref record; 316 of the 316 references it cites were found in a registry or an index.
Natural products: An evolving role in future drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The capsaicin receptor: a heat-activated ion channel in the pain pathway
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997) · Nature · doi:10.1038/39807 · Cited by 9,107
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,647
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Natural Products in Drug Discovery and Development
Cragg, G. M., Newman, D. J., & Snader, K. M. (1997) · Journal of Natural Products · doi:10.1021/np9604893 · Cited by 1,585
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
Chappuis, F., Sundar, S., Hailu, A., Ghalib, H., Rijal, S., Peeling, R. W., Alvar, J., & Boelaert, M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1748 · Cited by 1,490
Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran
Kim, H. M., Park, B. S., Kim, J.-I., Kim, S. E., Lee, J., Oh, S. C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O. J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.002 · Cited by 1,177
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Feling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390115 · Cited by 1,057
Conus Venoms: A Rich Source of Novel Ion Channel-Targeted Peptides
TERLAU, H., & OLIVERA, B. M. (2004) · Physiological Reviews · doi:10.1152/physrev.00020.2003 · Cited by 897
Coward, L., Barnes, N. C., Setchell, K. D. R., & Barnes, S. (1993) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00035a027 · Cited by 882
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
Szallasi, A., Cortright, D. N., Blum, C. A., & Eid, S. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2280 · Cited by 879
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Bross, P. F., Beitz, J. G., Chen, G., Chen, X., Duffy, E. J., Kieffer, L. V., Roy, S., Sridhara, R. N., Rahman, A., Williams, G., et al. (2001) · PubMed · Cited by 855
Rossetti, L., Smith, D., Shulman, G. I., Papachristou, D., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112981 · Cited by 809
Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., & Cellerino, A. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.038 · Cited by 784
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications
de la Lastra, C. A., & Villegas, I. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351156 · Cited by 740
Piekarz, R. L., Frye, R., Turner, M., Wright, J. J., Allen, S. L., Kirschbaum, M. H., Zain, J., Prince, H. M., Leonard, J. P., Geskin, L. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6150 · Cited by 740
Resveratrol: A review of preclinical studies for human cancer prevention
ATHAR, M., BACK, J., TANG, X., KIM, K., KOPELOVICH, L., BICKERS, D., & KIM, A. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.025 · Cited by 731
Lipid II as a target for antibiotics
Breukink, E., & de Kruijff, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 701
Chauhan, D., Catley, L., Li, G., Podar, K., Hideshima, T., Velankar, M., Mitsiades, C., Mitsiades, N., Yasui, H., Letai, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.013 · Cited by 694
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network
Rosen, H., & Goetzl, E. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1650 · Cited by 694
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
OMURA, S., IWAI, Y., HIRANO, A., NAKAGAWA, A., AWAYA, J., TSUCHIYA, H., TAKAHASHI, Y., & ASUMA, R. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.275 · Cited by 674
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M., & Mizui, Y. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.16 · Cited by 657
Pharmacological properties of the ubiquitous natural product betulin
Alakurtti, S., Mäkelä, T., Koskimies, S., & Yli-Kauhaluoma, J. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.006 · Cited by 650
Meng, W., Ellsworth, B. A., Nirschl, A. A., McCann, P. J., Patel, M., Girotra, R. N., Wu, G., Sher, P. M., Morrison, E. P., Biller, S. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701272q · Cited by 634
Johnson, J. R., Burnell-Nugent, M., Lossignol, D., Ganae-Motan, E. D., Potts, R., & Fallon, M. T. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.06.008 · Cited by 622
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA..
MORITO, K., HIROSE, T., KINJO, J., HIRAKAWA, T., OKAWA, M., NOHARA, T., OGAWA, S., INOUE, S., MURAMATSU, M., & MASAMUNE, Y. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.351 · Cited by 614
Erickson, H. K., Park, P. U., Widdison, W. C., Kovtun, Y. V., Garrett, L. M., Hoffman, K., Lutz, R. J., Goldmacher, V. S., & Blättler, W. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4489 · Cited by 584
Silybin and Silymarin - New and Emerging Applications in Medicine
Gazak, R., Walterova, D., & Kren, V. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941159 · Cited by 573
The Renaissance of Natural Products as Drug Candidates
Paterson, I., & Anderson, E. A. (2005) · Science · doi:10.1126/science.1116364 · Cited by 559
Betulinic Acid and Its Derivatives: A Review on their Biological Properties
Yogeeswari, P., & Sriram, D. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053202214 · Cited by 553
New aspects of natural products in drug discovery
Lam, K. S. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.04.001 · Cited by 531
Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia
Olincy, A., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., Allensworth, D., Ellis, J., Zerbe, G. O., Leonard, S., Stevens, K. E., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.630 · Cited by 527
Towle, M. J., Salvato, K. A., Budrow, J., Wels, B. F., Kuznetsov, G., Aalfs, K. K., Welsh, S., Zheng, W., Seletsky, B. M., Palme, M. H., et al. (2001) · PubMed · Cited by 483
Injectable Paromomycin for Visceral Leishmaniasis in India
Sundar, S., Jha, T. K., Thakur, C. P., Sinha, P. K., & Bhattacharya, S. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066536 · Cited by 471
Fujioka, T., Kashiwada, Y., Kilkuskie, R. E., Cosentino, L. M., Ballas, L. M., Jiang, J. B., Janzen, W. P., Chen, I.-S., & Lee, K.-H. (1994) · Journal of Natural Products · doi:10.1021/np50104a008 · Cited by 470
Natural products ? a simple model to explain chemical diversity
Firn, R. D., & Jones, C. G. (2003) · Natural Product Reports · doi:10.1039/b208815k · Cited by 467
Schoner, W., & Scheiner-Bobis, G. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00098.2007 · Cited by 456
Straus, S. K., & Hancock, R. E. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.009 · Cited by 446
Wade, D. T., Robson, P., House, H., Makela, P., & Aram, J. (2003) · Clinical Rehabilitation · doi:10.1191/0269215503cr581oa · Cited by 441
Nurmikko, T. J., Serpell, M. G., Hoggart, B., Toomey, P. J., Morlion, B. J., & Haines, D. (2007) · Pain · doi:10.1016/j.pain.2007.08.028 · Cited by 431
Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1127-1134.2005 · Cited by 425
Knapper, S., Burnett, A. K., Littlewood, T., Kell, W. J., Agrawal, S., Chopra, R., Clark, R., Levis, M. J., & Small, D. (2006) · Blood · doi:10.1182/blood-2006-04-015560 · Cited by 413
The value of natural products to future pharmaceutical discovery
Baker, D. D., Chu, M., Oza, U., & Rajgarhia, V. (2007) · Natural Product Reports · doi:10.1039/b602241n · Cited by 413
Mori, A., Lehmann, S., O'Kelly, J., Kumagai, T., Desmond, J. C., Pervan, M., McBride, W. H., Kizaki, M., & Koeffler, H. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0087 · Cited by 399
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Sang, C., Tanaka, F., Inukai, A., Doyu, M., & Sobue, G. (2005) · Nature Medicine · doi:10.1038/nm1298 · Cited by 395
Small Molecule Natural Products in the Discovery of Therapeutic Agents: The Synthesis Connection
Wilson, R. M., & Danishefsky, S. J. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo0610053 · Cited by 387
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
McCoy, K. S., Quittner, A. L., Oermann, C. M., Gibson, R. L., Retsch-Bogart, G. Z., & Montgomery, A. B. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1804oc · Cited by 356
Bey, E. A., Bentle, M. S., Reinicke, K. E., Dong, Y., Yang, C.-R., Girard, L., Minna, J. D., Bornmann, W. G., Gao, J., & Boothman, D. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702176104 · Cited by 354
Camptothecin and Taxol: Historic Achievements in Natural Products Research
Oberlies, N. H., & Kroll, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030498t · Cited by 353
The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
Lambert, D. M., & Fowler, C. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058183t · Cited by 350
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 342
Jirousek, M. R., Gillig, J. R., Gonzalez, C. M., Heath, W. F., McDonald, J. H., Neel, D. A., Rito, C. J., Singh, U., Stramm, L. E., Melikian-Badalian, A., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950588y · Cited by 339
TRPV1+ Sensory Neurons Control β Cell Stress and Islet Inflammation in Autoimmune Diabetes
Razavi, R., Chan, Y., Afifiyan, F. N., Liu, X. J., Wan, X., Yantha, J., Tsui, H., Tang, L., Tsai, S., Santamaria, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.038 · Cited by 336
Modi, S., Stopeck, A. T., Gordon, M. S., Mendelson, D., Solit, D. B., Bagatell, R., Ma, W., Wheler, J., Rosen, N., Norton, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.7960 · Cited by 335
George, P., Bali, P., Annavarapu, S., Scuto, A., Fiskus, W., Guo, F., Sigua, C., Sondarva, G., Moscinski, L., Atadja, P., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3413 · Cited by 324
Sudek, S., Lopanik, N. B., Waggoner, L. E., Hildebrand, M., Anderson, C., Liu, H., Patel, A., Sherman, D. H., & Haygood, M. G. (2007) · Journal of Natural Products · doi:10.1021/np060361d · Cited by 314
Ziconotide: a review of its pharmacology and use in the treatment of pain
McGivern, J. G. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2007.3.1.69 · Cited by 310
Semisynthetic Maytansine Analogues for the Targeted Treatment of Cancer
Widdison, W. C., Wilhelm, S. D., Cavanagh, E. E., Whiteman, K. R., Leece, B. A., Kovtun, Y., Goldmacher, V. S., Xie, H., Steeves, R. M., Lutz, R. J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060319f · Cited by 309
Chintharlapalli, S., Papineni, S., Ramaiah, S. K., & Safe, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3735 · Cited by 297
Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo
Whitby, K., Pierson, T. C., Geiss, B., Lane, K., Engle, M., Zhou, Y., Doms, R. W., & Diamond, M. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8698-8706.2005 · Cited by 295
Mullarkey, M., Rose, J. R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W. J., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044487 · Cited by 292
Treatment of Clostridium difficile Infection
Gerding, D. N., Muto, C. A., & Owens, Jr. (2008) · Clinical Infectious Diseases · doi:10.1086/521860 · Cited by 287
Saunier, B., Kilker, R. D., Tkacz, J. S., Quaroni, A., & Herscovics, A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45358-1 · Cited by 283
Capsaicin (TRPV1 Agonist) Therapy for Pain Relief: Farewell or Revival?
Knotkova, H., Pappagallo, M., & Szallasi, A. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e318158ed9e · Cited by 279
Lee, K.-H. (2010) · Journal of Natural Products · doi:10.1021/np900821e · Cited by 278
The way forward in HCV treatment — finding the right path
Manns, M. P., Foster, G. R., Rockstroh, J. K., Zeuzem, S., Zoulim, F., & Houghton, M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2411 · Cited by 278
A Novel Mechanism for the Inhibition of Hyaluronan Biosynthesis by 4-Methylumbelliferone
Kakizaki, I., Kojima, K., Takagaki, K., Endo, M., Kannagi, R., Ito, M., Maruo, Y., Sato, H., Yasuda, T., Mita, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405918200 · Cited by 277
Mita, M. M., Mita, A. C., Chu, Q. S., Rowinsky, E. K., Fetterly, G. J., Goldston, M., Patnaik, A., Mathews, L., Ricart, A. D., Mays, T., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0345 · Cited by 273
Betulinic Acid and Dihydrobetulinic Acid Derivatives as Potent Anti-HIV Agents
Kashiwada, Y., Hashimoto, F., Cosentino, L. M., Chen, C.-H., Garrett, P. E., & Lee, K.-H. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950922q · Cited by 272
Noel, G. J., Bush, K., Bagchi, P., Ianus, J., & Strauss, R. S. (2008) · Clinical Infectious Diseases · doi:10.1086/526527 · Cited by 270
Chackalamannil, S., Wang, Y., Greenlee, W. J., Hu, Z., Xia, Y., Ahn, H.-S., Boykow, G., Hsieh, Y., Palamanda, J., Agans-Fantuzzi, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800180e · Cited by 269
Vascular disrupting agents in clinical development
Hinnen, P., & Eskens, F. A. L. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603694 · Cited by 263
Kuznetsov, G., Towle, M. J., Cheng, H., Kawamura, T., TenDyke, K., Liu, D., Kishi, Y., Yu, M. J., & Littlefield, B. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1169 · Cited by 262
Nicholson, B., Lloyd, G. K., Miller, B. R., Palladino, M. A., Kiso, Y., Hayashi, Y., & Neuteboom, S. T. C. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000182745.01612.8a · Cited by 260
Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class
Haynes, R. K., Fugmann, B., Stetter, J., Rieckmann, K., Heilmann, H., Chan, H., Cheung, M., Lam, W., Wong, H., Croft, S. L., et al. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503071 · Cited by 260
Williams, M. E., Bolton, W. K., Khalifah, R. G., Degenhardt, T. P., Schotzinger, R. J., & McGill, J. B. (2007) · American Journal of Nephrology · doi:10.1159/000108104 · Cited by 253
Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease
Lieberman, R. L., Wustman, B. A., Huertas, P., Powe, A. C., Pine, C. W., Khanna, R., Schlossmacher, M. G., Ringe, D., & Petsko, G. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio850 · Cited by 245
Triterpenoid CDDO-Me Blocks the NF-κB Pathway by Direct Inhibition of IKKβ on Cys-179
Ahmad, R., Raina, D., Meyer, C., Kharbanda, S., & Kufe, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607160200 · Cited by 238
Kitagawa, H., Takenouchi, T., Azuma, R., Wesnes, K. A., Kramer, W. G., Clody, D. E., & Burnett, A. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300028 · Cited by 238
Soy Food Consumption and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
Hwang, Y. W., Kim, S. Y., Jee, S. H., Kim, Y. N., & Nam, C. M. (2009) · Nutrition and Cancer · doi:10.1080/01635580902825639 · Cited by 234
Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C
Propper, D. J., McDonald, A. C., Man, A., Thavasu, P., Balkwill, F., Braybrooke, J. P., Caponigro, F., Graf, P., Dutreix, C., Blackie, R., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1485 · Cited by 233
Robertson, M. J., Kahl, B. S., Vose, J. M., de Vos, S., Laughlin, M., Flynn, P. J., Rowland, K., Cruz, J. C., Goldberg, S. L., Musib, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3146 · Cited by 232
Tidswell, M., Tillis, W., LaRosa, S. P., Lynn, M., Wittek, A. E., Kao, R., Wheeler, J., Gogate, J., & Opal, S. M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b07b78 · Cited by 229
Haynes, R. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776743129 · Cited by 224
Natural products as a screening resource
Harvey, A. L. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.08.012 · Cited by 223
Drug discovery from natural products
Gullo, V. P., McAlpine, J., Lam, K. S., Baker, D., & Petersen, F. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-006-0107-2 · Cited by 222
Inhibitors of HIV-1 replication that inhibit HIV integrase.
Robinson, W. E., Reinecke, M. G., Abdel-Malek, S., Jia, Q., & Chow, S. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6326 · Cited by 222
Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter
Sharpe, I. A., Gehrmann, J., Loughnan, M. L., Thomas, L., Adams, D. A., Atkins, A., Palant, E., Craik, D. J., Adams, D. J., Alewood, P. F., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-902 · Cited by 220
Hebeisen, P., Heinze-Krauss, I., Angehrn, P., Hohl, P., Page, M. G. P., & Then, R. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.825-836.2001 · Cited by 219
Steet, R. A., Chung, S., Wustman, B., Powe, A., Do, H., & Kornfeld, S. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605928103 · Cited by 218
Kiuchi, M., Adachi, K., Kohara, T., Minoguchi, M., Hanano, T., Aoki, Y., Mishina, T., Arita, M., Nakao, N., Ohtsuki, M., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000173z · Cited by 217
Huperzine A, A Potential Therapeutic Agent for Treatment of Alzheimer's Disease
Bai, D. L., Tang, X. C., & He, X. C. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003375281 · Cited by 216
Cancer Therapy with ß-Lapachone
Pardee, A., Li, Y., & Li, C. (2002) · Current Cancer Drug Targets · doi:10.2174/1568009023333854 · Cited by 215
Cappelletty, D., & Eiselstein‐McKitrick, K. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.369 · Cited by 205
Shaw, K. T. Y., Utsuki, T., Rogers, J., Yu, Q.-S., Sambamurti, K., Brossi, A., Ge, Y.-W., Lahiri, D. K., & Greig, N. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131152998 · Cited by 205
CEP-1347 (KT7515), a Semisynthetic Inhibitor of the Mixed Lineage Kinase Family
Maroney, A. C., Finn, J. P., Connors, T. J., Durkin, J. T., Angeles, T., Gessner, G., Xu, Z., Meyer, S. L., Savage, M. J., Greene, L. A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011601200 · Cited by 204
Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms
Szallasi, A., & Gunthorpe, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783330754 · Cited by 199
Schnur, R. C., Corman, M. L., Gallaschun, R. J., Cooper, B. A., Dee, M. F., Doty, J. L., Muzzi, M. L., Moyer, J. D., & DiOrio, C. I. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00019a010 · Cited by 199
Crystal Structure and Molecular Modeling of 17-DMAG in Complex with Human Hsp90
Jez, J. M., Chen, J. C.-H., Rastelli, G., Stroud, R. M., & Santi, D. V. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00075-9 · Cited by 197
Deoxynojirimycin: synthesis and biological activity
Hughes, A. B., & Rudge, A. J. (1994) · Natural Product Reports · doi:10.1039/np9941100135 · Cited by 197
Breedt, J., Teras, J., Gardovskis, J., Maritz, F. J., Vaasna, T., Ross, D. P., Gioud-Paquet, M., Dartois, N., Ellis-Grosse, E. J., & Loh, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4658-4666.2005 · Cited by 192
Combretastatin A4 phosphate: background and current clinical status
Young, S. L., & Chaplin, D. J. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1171 · Cited by 192
Flavonoid, Silibinin, Inhibits Proliferation and Promotes Cell-Cycle Arrest of Human Colon Cancer
Hogan, F. S., Krishnegowda, N. K., Mikhailova, M., & Kahlenberg, M. S. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.03.080 · Cited by 191
Louie, T. J., Emery, J., Krulicki, W., Byrne, B., & Mah, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-07 · Cited by 190
Diversity of the Neurotoxic Conus Peptides: A Model for Concerted Pharmacological Discovery
Olivera, B. M., & Teichert, R. W. (2007) · Molecular Interventions · doi:10.1124/mi.7.5.7 · Cited by 189
Vitamin B biosynthesis in plants
Roje, S. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.03.038 · Cited by 189
Diazepinomicin, a New Antimicrobial Alkaloid from a Marine Micromonospora sp.
Charan, R. D., Schlingmann, G., Janso, J., Bernan, V., Feng, X., & Carter, G. T. (2004) · Journal of Natural Products · doi:10.1021/np040042r · Cited by 184
Sandall, D. W., Satkunanathan, N., Keays, D. A., Polidano, M. A., Liping, X., Pham, V., Down, J. G., Khalil, Z., Livett, B. G., & Gayler, K. R. (2003) · Biochemistry · doi:10.1021/bi034043e · Cited by 182
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley, M. O., Webb, N. L., Anthony, F. H., Devanesan, P. D., Witman, P. A., Hemamalini, S., Chander, M. C., Baker, S. D., He, L., Horwitz, S. B., et al. (2001) · PubMed · Cited by 180
The Biology Behind mTOR Inhibition in Sarcoma
Wan, X., & Helman, L. J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-1007 · Cited by 180
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · Chemical Reviews · doi:10.1021/cr030107f · Cited by 177
Challacombe, J. M., Suhrbier, A., Parsons, P. G., Jones, B., Hampson, P., Kavanagh, D., Rainger, G. E., Morris, M., Lord, J. M., Le, T. T. T., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8123 · Cited by 177
Next generation topoisomerase I inhibitors: Rationale and biomarker strategies
Teicher, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.016 · Cited by 176
Hwang, D., & Noguchi, T. (2007) · Advances in food and nutrition research · doi:10.1016/s1043-4526(06)52004-2 · Cited by 176
Fumagillin (H-3), a New Antibiotic with Amebicidal Properties
McCowen, M. C., Callender, M. E., & Lawlis, J. F. (1951) · Science · doi:10.1126/science.113.2930.202 · Cited by 172
The Role of Pharmacognosy in Modern Medicine and Pharmacy
Jones, W., Chin, Y.-W., & Kinghorn, A. (2006) · Current Drug Targets · doi:10.2174/138945006776054915 · Cited by 164
Norton, R. S., & Olivera, B. M. (2006) · Toxicon · doi:10.1016/j.toxicon.2006.07.022 · Cited by 163
Ma, S., Boerner, J. E., TiongYip, C., Weidmann, B., Ryder, N. S., Cooreman, M. P., & Lin, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00310-06 · Cited by 163
Macrocyclic ketone analogues of halichondrin B
Zheng, W., Seletsky, B. M., Palme, M. H., Lydon, P. J., Singer, L. A., Chase, C. E., Lemelin, C. A., Shen, Y., Davis, H., Tremblay, L., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.069 · Cited by 163
Treatment Options in Knee Osteoarthritis: The Patient's Perspective
Fraenkel, L., Bogardus, S. T., Concato, J., & Wittink, D. R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1299 · Cited by 161
TAKAHASHI, I., Saitoh, Y., Yoshida, M., Sano, H., Nakano, H., Morimoto, M., & Tamaoki, T. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.571 · Cited by 158
Soares, D. G., Escargueil, A. E., Poindessous, V., Sarasin, A. R., de Gramont, A., Bonatto, D., Henriques, J. A. P., & Larsen, A. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609877104 · Cited by 156
Talbot, G. H., Thye, D. A., Das, A., & Ge, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00590-07 · Cited by 155
Chemistry, Pharmacology, and Clinical Efficacy of the Chinese Nootropic Agent Huperzine A
Kozikowski, A. P., & Tückmantel, W. (1999) · Accounts of Chemical Research · doi:10.1021/ar9800892 · Cited by 150
Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid
Kruczynski, A., Barret, J.-M. M., Etiévant, C., Colpaert, F. C., Fahy, J., & Hill, B. T. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00505-4 · Cited by 149
Nakamura, Y., Yogosawa, S., Izutani, Y., Watanabe, H., Otsuji, E., & Sakai, T. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-100 · Cited by 149
Targeting Checkpoint Kinase 1 in Cancer Therapeutics
Tse, A. N., Carvajal, R. D., & Schwartz, G. K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2793 · Cited by 148
Wang, B.-S., Wang, H., Wei, Z.-H., Song, Y., Zhang, L., & Chen, H. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0189-x · Cited by 148
Mechanism of Action of Streptogramins and Macrolides
Vannuffel, P., & COCITO, C. G. (1996) · Drugs · doi:10.2165/00003495-199600511-00006 · Cited by 147
Ishikawa, T., Matsunaga, N., TAWADA, H., Kuroda, N., Nakayama, Y., Ishibashi, Y., TOMIMOTO, M., Ikeda, Y., Tagawa, Y., Iizawa, Y., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00126-3 · Cited by 147
DiJoseph, J. F., Dougher, M. M., Kalyandrug, L. B., Armellino, D. C., Boghaert, E. R., Hamann, P. R., Moran, J. K., & Damle, N. K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1905 · Cited by 140
Inhalation of Moli1901 in Patients With Cystic Fibrosis
Grasemann, H., Stehling, F., Brunar, H., Widmann, R. S., Laliberte, T. W., Molina, L., Döring, G., & Ratjen, F. A. (2007) · CHEST Journal · doi:10.1378/chest.06-2085 · Cited by 140
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · ChemInform · doi:10.1002/chin.200524271 · Cited by 138
Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men
D, A. O. M., & Stevens, K. E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.015 · Cited by 135
The mechanism of action of ramoplanin and enduracidin
Fang, X., Tiyanont, K., Zhang, Y., Wanner, J., Boger, D. L., & Walker, S. (2005) · Molecular BioSystems · doi:10.1039/b515328j · Cited by 135
DiJoseph, J. F., Dougher, M. M., Armellino, D. C., Evans, D. Y., & Damle, N. K. (2007) · Leukemia · doi:10.1038/sj.leu.2404866 · Cited by 134
Kem, W. R., Mahnir, V. M., Papke, R. L., & Lingle, C. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37134-4 · Cited by 132
SAKAI, T., Sameshima, T., Matsufuji, M., Kawamura, N., Dobashi, K., & Mizui, Y. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.173 · Cited by 131
Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia
Bai, R., Friedman, S., Pettit, G. R., et al. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90153-a · Cited by 129
Vesicular monoamine transporter 2: Role as a novel target for drug development
Zheng, G., Dwoskin, L. P., & Crooks, P. A. (2006) · The AAPS Journal · doi:10.1208/aapsj080478 · Cited by 125
Quintás‐Cardama, A., Kantarjian, H. M., Garcia‐Manero, G., O'Brien, S. M., Faderl, S. H., Estrov, Z. E., Giles, F. J., Murgo, A. J., Laddie, N., Verstovšek, S., et al. (2006) · Cancer · doi:10.1002/cncr.22398 · Cited by 125
Klar, U., Buchmann, B., Schwede, W., Skuballa, W., Hoffmann, J., & Lichtner, R. B. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602785 · Cited by 124
History of the discovery of cyclosporin and of its early pharmacological development.
Borel, J. F. (2002) · PubMed · Cited by 123
Parenti, G., Zuppaldi, A., Pittis, M. G., Tuzzi, M. R., Annunziata, I., Meroni, G., Porto, C., Donaudy, F., Rossi, B., Rossi, M., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300074 · Cited by 121
Preclinical discovery of ixabepilone, a highly active antineoplastic agent
Lee, F. Y., Borzilleri, R. M., Fairchild, C. R., Kamath, A. V., Smykla, R. A., Kramer, R. A., & Vite, G. D. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0724-8 · Cited by 121
Brooks, T. A., Minderman, H., O’Loughlin, K. L., Pera, P. J., Ojima, I., Baer, M. R., Bernacki, R. J., & Brooks, T. A. (2003) · PubMed · Cited by 119
Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a Derivatives
Kaneko, M., Saito, Y., Saito, H., Matsumoto, T., Matsuda, Y., Vaught, J. L., Dionne, C. A., Angeles, T. S., Glicksman, M. A., Neff, N. T., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970031d · Cited by 119
YOUNGREN, J. F., Gable, K., Peñaranda, C., Maddux, B. A., Zavodovskaya, M., Lobo, M., Campbell, M. J., Kerner, J., & Goldfine, I. D. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-6939-z · Cited by 117
Cvetkovi, R. S., & Plosker, G. L. (2007) · Drugs · doi:10.2165/00003495-200767060-00008 · Cited by 117
Hennerici, M. G., Kay, R., Bogousslavsky, J., Lenzi, G. L., Verstraete, M., & Orgogozo, J. M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69776-6 · Cited by 117
Ptak, R. G., Gallay, P. A., Jochmans, D., Halestrap, A. P., Rüegg, U. T., Pallansch, L. A., Bobardt, M. D., de Béthune, M., Neyts, J. H., Clercq, E. D., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01324-07 · Cited by 115
Debono, M., Turner, W. W., LaGrandeur, L., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00017a012 · Cited by 114
Review of UCN‐01 Development: A Lesson in the Importance of Clinical Pharmacology
Fuse, E., Kuwabara, T., Sparreboom, A., Sausville, E. A., & Figg, W. D. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005274549 · Cited by 113
Cisternino, S., Bourasset, F., Archimbaud, Y., Sémiond, D., Sanderink, G., & Scherrmann, J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705150 · Cited by 111
Monoclonal Antibodies in the Treatment of Non-Hodgkin???s Lymphoma
Fanale, M. A., & Younes, A. (2007) · Drugs · doi:10.2165/00003495-200767030-00002 · Cited by 111
Potential for improvement of docetaxel-based chemotherapy: a pharmacological review
Engels, F. K., Sparreboom, A., Mathôt, R. A. A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602698 · Cited by 111
Yang, S. S., Cragg, G. M. L., Newman, D. J., & Bader, J. P. (2001) · Journal of Natural Products · doi:10.1021/np0003995 · Cited by 110
Deforolimus (AP23573) a novel mTOR inhibitor in clinical development
Mita, M. M., Sankhala, K. K., Abdel-Karim, I., Mita, A. C., & Giles, F. J. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802556485 · Cited by 109
Effect of the Second-Generation Vascular Disrupting Agent OXi4503 on Tumor Vascularity
Salmon, H. W., & Siemann, D. W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0163 · Cited by 108
Efficacy of Selected Natural Products as Therapeutic Agents against Cancer
Banerjee, S., Wang, Z., Mohammad, M., Sarkar, F. H., & Mohammad, R. M. (2008) · Journal of Natural Products · doi:10.1021/np0705716 · Cited by 107
Retsch‐Bogart, G. Z., Burns, J. L., Otto, K., Liou, T. G., McCoy, K., Oermann, C. M., Gibson, R. L., & AZLI Phase II Study Group (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20736 · Cited by 107
Apple Trees to Sodium Glucose Co-Transporter Inhibitors: A Review of SGLT2 Inhibition
White, J. R. (2010) · Clinical Diabetes · doi:10.2337/diaclin.28.1.5 · Cited by 106
Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review
Lanternier, F., Boutboul, D., Menotti, J., Chandesris, M. O., Sarfati, C., Mamzer Bruneel, M. F., Calmus, Y., Mechaï, F., Viard, J. P., Lecuit, M., et al. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2008.00347.x · Cited by 101
(-)-Phenylahistin Arrests Cells in Mitosis by Inhibiting Tubulin Polymerization.
Kanoh, K., KOHNO, S., Katada, J., TAKAHASHI, J., & Uno, I. (1999) · The Journal of Antibiotics · doi:10.7164/antibiotics.52.134 · Cited by 101
Jasinski, D., & Krishnan, S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108093841 · Cited by 100
Lovelace, E. S., Armishaw, C. J., Colgrave, M. L., Wahlstrom, M. E., Alewood, P. F., Daly, N. L., & Craik, D. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060299h · Cited by 100
Seo, H., & Surh, Y. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00234-0 · Cited by 99
BURSTEIN, S. H., Audette, C. A., Breuer, A., Devane, W. A., Colodner, S., Doyle, S. A., & Mechoulam, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00095a007 · Cited by 99
Structure-activity relationships of illudins: analogs with improved therapeutic index.
McMorris, T. C., Kelner, M. J., Wang, W., Estes, L. A., Montoya, M. A., & Taetle, R. (1992) · The Journal of Organic Chemistry · doi:10.1021/jo00051a037 · Cited by 99
Credito, K. L., & Appelbaum, P. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4430-4434.2004 · Cited by 97
Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.
Durantel, D. (2009) · PubMed · Cited by 96
Hagen, N. A., du Souich, P., Lapointe, B. J., Ong-Lam, M., Dubuc, B., Walde, D., Love, R., & Ngoc, A. H. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.05.011 · Cited by 96
Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic
Saravolatz, L. D., Billeter, M., Zervos, M., Chen, A. Y., Dalovisio, J. R., & Kurukularatne, C. (2008) · Clinical Infectious Diseases · doi:10.1086/526772 · Cited by 96
PST2238: A New Antihypertensive Compound That Antagonizes the Long-Term Pressor Effect of Ouabain
Ferrari, P., Torielli, L., Ferrandi, M., Padoani, G., Duzzi, L., Florio, M., Conti, F., Melloni, P., Vesci, L., Corsico, N., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37374-4 · Cited by 95
Baumruker, T., Billich, A., & Brinkmann, V. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.3.283 · Cited by 94
Vivas, L., Rattray, L., Stewart, L. B., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl563 · Cited by 93
Shue, Y., Sears, P. S., Shangle, S., Walsh, R. B., Lee, C., Gorbach, S. L., Okumu, F. W., & Preston, R. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01045-07 · Cited by 93
Xiao, Y., Li, S., Niu, S., Ma, L., Zhang, G., Zhang, H., Zhang, G., Ju, J., & Zhang, C. (2010) · Journal of the American Chemical Society · doi:10.1021/ja109445q · Cited by 92
Kissin, I. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318162cfa3 · Cited by 92
Hagen, N. A., Fisher, K., Lapointe, B. J., et al. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.11.008 · Cited by 91
Ganguly, A., Das, B., Roy, A., Sen, N., Dasgupta, S. B., Mukhopadhayay, S., & Majumder, H. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1615 · Cited by 91
Dalhoff, A., Janjić, N., & ECHOLS, R. M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.003 · Cited by 91
Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination.
Hochlowski, J. E., Swanson, S., RANFRANZ, L. M., Whittern, D. N., BUKO, A. M., & McAlpine, J. B. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.575 · Cited by 88
Nuengchamnong, N., Ingkaninan, K., Kaewruang, W., Wongareonwanakij, S., & Hongthongdaeng, B. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.03.031 · Cited by 88
Whitby, K., Taylor, D. L., Patel, D., Ahmed, P. S., & Tyms, A. S. (2004) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020401500304 · Cited by 88
Boni, J. P., Leister, C. A., Bender, G., Fitzpatrick, V., Twine, N. C., Stover, J. A., Dorner, A. J., Immermann, F., & Burczynski, M. E. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.025 · Cited by 87
Alkaloids as potential anti-tubercular agents
Kishore, N., Mishra, B. B., Tripathi, V., & Tiwari, V. K. (2009) · Fitoterapia · doi:10.1016/j.fitote.2009.01.002 · Cited by 86
Self-citationTigecycline: A new glycylcycline antimicrobial agent
Kasbekar, N. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050487 · Cited by 86
Cited by
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572
A Historical Overview of Natural Products in Drug Discovery
Dias, D. A., Urban, S., & Roessner, U. (2012) · Metabolites · doi:10.3390/metabo2020303 · Cited by 1,958
Counting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Cu-Catalyzed Click Reaction in Carbohydrate Chemistry
Tiwari, V. K., Mishra, B. B., Mishra, K. B., Mishra, N., Singh, A. S., & Chen, X. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00408 · Cited by 862
Self-citationSeca, A., & Pinto, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010263 · Cited by 686
Metadata
- Authors
- Mishra, B. B., & Tiwari, V. K.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 46
- Issue
- 10
- Pages
- 4769-4807
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W1982728268
- Cited by
- 860
- References
- 316
- FWCI
- 32.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.